BNTX BIONTECH SE-ADR
2026Q2 · CUSIP 09075V102 · Sector: Healthcare & Biotech
Fund flows are within the usual range
276 funds held BNTX at the end of 2026Q2, up 5 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $3.3B(YoY +4.3%). BNTX has had 10 buying rushes in its history, and the price moved +43.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.
How many funds owned it, quarter by quarter
Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.
What happened after each past buying rush 10 times in its history
| Quarter of the rush | How unusual then | Price, next 3 months | Price, next 6 months |
|---|---|---|---|
| 2025Q4 | Top 20% | -18.2% | — |
| 2023Q4 | Top 20% | -1.2% | -1.9% |
| 2022Q4 | Top 10% | -25.8% | -21.9% |
| 2021Q3 | Top 5% | -42.1% | -38.3% |
| 2021Q2 | Top 5% | -29.1% | -54.5% |
| 2021Q1 | Top 20% | +82.8% | +29.6% |
| 2020Q4 | Top 20% | +76.7% | +223.1% |
| 2020Q3 | Top 5% | +26.7% | +116.4% |
| 2020Q2 | Top 5% | +50.9% | +61.6% |
| 2020Q1 | Top 5% | +16.8% | +76.2% |
These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.
Show all the numbers (large funds, value held, options…) ▾ Collapse ▴
These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.
8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.
Fundamentals
As of 2025-12-31 · SEC filings (XBRL)
Email me the next update
2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.